Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/10 16:50 | 1/19/10 | GTCB | Health | BioPrd | Biological Products, (No Diag | Scotland Richard A | MA | O | SVP,Regu | S | -17 | 1.13 | 0 | -15 | -31 | 32 | I | ||||||||||||||
3/13/08 16:09 | 3/12/08 | GTCB | Health | BioPrd | Biological Products, (No Diag | Liposky Gregory F | MA | O | SVP,Oper | S | -13 | 0.5637 | 0 | -23 | -25 | 68 | D | ||||||||||||||
3/12/08 17:13 | 3/12/08 | GTCB | Health | BioPrd | Biological Products, (No Diag | Woloshen Daniel S | MA | O | SVP,GC | S | -10 | 0.5705 | 0 | -17 | -14 | 101 | D | ||||||||||||||
12/22/06 16:45 | 12/22/06 | GTCB | Health | BioPrd | Biological Products, (No Diag | Woloshen Daniel S | MA | O | SVP,GC | S | -8 | 1.10 | 0 | -8 | -8 | 81 | D | ||||||||||||||
3/21/06 17:31 | 3/17/06 | GTCB | Health | BioPrd | Biological Products, (No Diag | Liposky Gregory F | MA | O | SVP,Oper | S | -20 | 1.01 | 0 | -20 | -33 | 42 | B |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |